MedTrace Logo

Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

NCT02128503 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2017-04-25

No results posted yet for this study

Summary

This study aims to determine the prevalence of HBV infection in patients with IBD and rheumatologic disease, and to assess the impact of immunosuppressive therapy on viral load and clinical course of IBD patients.

Conditions

Interventions

OTHER

HBV DNA level monitoring

HBV DNV level being monitoring regularly

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Siew Chien Ng · Chinese University of Hong Kong

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-10-16
Completion
2015-10-16

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128503 on ClinicalTrials.gov